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Abstract
Background: Low prevalence of substance-use disorder has been reported in adults with autism. However, on a
superficial level, adults with high-functioning autism (HFA) display a ‘normal’ façade when they drink alcohol, which
may explain why their alcohol dependency is not better diagnosed.
Case presentation: Here, we report two cases of HFA adults who use alcohol and psychostimulants to cope with
their anxiety and improve their cognitive abilities and social skills. We analyze how neurocognitive traits associated
with HFA may be potential triggers for substance-use disorder.
Conclusion: Better identification of autism and its cognitive impairments, which may be vulnerability traits for
developing substance-use disorders, could help improve the diagnosis and treatment of substance-use disorders
among this population.
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Background
Several psychiatric co-morbidities have been associated
with High-Functioning Autism (HFA), but a surprisingly
low prevalence of substance-use disorders (SUDs) has
been reported in this population [1] (results of a study
involving 122 patients). Furthermore, another study [2]
has reported that teenagers with HFA had a relatively
low risk of developing a co-morbid SUD. This is attrib-
uted to the fact that they display few sensation-seeking
traits and an introverted personality overall. Sizoo et al.
[3] showed higher rates of co-morbid SUD in patients
suffering from Attention deficit hyperactivity disorder
(ADHD) compared with those with Autism Spectrum
Disorder (ASD) (58 % versus 30 %), but their study did
not focus on HFA. The aforementioned studies focused
on the prevalence of SUDs among individuals with ASD,
rather than on the prevalence of patients suffering from
ASD among patients with SUDs. In his book, Matthew
Tinsley, an adult with HFA and alcohol dependency,
reported that alcohol use in this population may be a
way for them “to cope with their anxiety, to maintain
friendships, to give access to a whole host of relation-
ships and even to sustain careers” [4]. According to
these authors, adults with HFA may superficially display
a ‘normal’ façade when they drink alcohol, which may
explain why their alcohol dependency is not better
diagnosed. On a neuropsychological level, similar to
what has been reported in alcohol-dependent patients,
the maladaptive use of alcohol, which is probably under-
estimated in this population, might be connected with
their poor social problem-solving skills, such as poor
self-reported empathy, and impaired emotion recogni-
tion skills [5]. In addition to symptoms of anxiety, which
are part of the clinical picture, the main neurocognitive
traits associated with autism are social cognition impair-
ments, a local processing bias or weak central coherence,
and executive dysfunction [6]. These traits may be risk
factors for developing alcohol dependency because they
are related to anxiety and social problem-solving skills.
To examine this hypothesis, in this paper we present a
detailed clinical and neurocognitive description of two
patients with HFA and a co-morbid SUD.
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Case presentation
Mr. B. and Mr. T.
Mr. B., a 45-year-old single man, was admitted to our
psychiatric department for the first time in 2009. He was
socially withdrawn. Upon being admitted to our depart-
ment, he requested treatment for anxiety and major
depression co-morbid with alcohol dependency. As he de-
scribed it, his depressive episodes in the past could rapidly
switch to mania. The current episode had lasted for
2 months. When we met him, he presented with a sad
mood associated with a worsening of symptoms in the
morning hours, early-morning waking, psychomotor re-
tardation, weight loss, and excessive guilt. His constant anx-
iety led him to spend the whole day, and sometimes the
whole night, wandering the streets. He had a very rigid
schedule and an impressive calendar memory. His social
behavior was aloof and naïve. For example, due to his diffi-
culty with mental state attribution, he might give his house
keys to complete strangers if asked to do so. His communi-
cation style was very detailed, egocentric and literal. He
only showed an interest in talking about his main passions,
such as detailed historical events and politics. Mr. B.
explained that ever since early childhood he had always
been lonely and had always lacked “social intelligence.” He
displayed many types of ritualistic and restricted behaviors.
For example, he bought the same food in the supermarket
every day, his time was spent on the same activities, at the
same time, every day, and his interests were restricted to
history, as well as international and national politics. When
something unexpected happened, like a tram being late, he
showed increased anxiety and an intense craving for alcohol
and smoking which led him to consume both substances in
a compulsive manner. The patient reported a heightening
of his attentional capacity after smoking, and lower anxiety
levels after drinking alcohol. Owing to alcohol intoxication,
he stopped tending to his apartment and accumulated a lot
of debts. In the past, he had tried to cut back on his drink-
ing, but such attempts had lasted less than a week. His
addiction to alcohol and cigarettes began when he was
an adolescent. During the first interview, he was diag-
nosed as tobacco and alcohol dependent according to
DSM-IV criteria (Fagerström score: 10; Alcohol use dis-
orders test = 35, >12), as well as suffering from a major
depressive episode.
In his psychiatric history, he had been admitted to
other departments of psychiatry three times for the same
reason between 1989 and 2009. Psychiatrists concluded
he was suffering from a bipolar disorder coupled with
alcohol abuse. His father, whom Mr. B described as a
lonely man with many hobbies, had autistic traits and
was being treated for bipolar disorder. At the age of 8,
he had no school friends and was only interested in
reading books. He had no interest in playing with other
children or in sports. Although no significant delay was
ever reported in language or academic functioning, ever
since his childhood, Mr. B. has been described as aloof.
He walks on tiptoe, cannot ride a bicycle or tie his
shoelaces, and his handwriting is described as “clumsy”.
During his early adult life, he excelled academically,
studying political science and international relations be-
fore obtaining a degree in ethnological science. When he
was diagnosed with bipolar disorder in 1989, he stopped
studying, and has been employed only for short periods.
His developmental history, as well as his current clin-
ical picture, is consistent with ASD diagnosis according
to the DSM-IV criteria and quantitative screening and
diagnostic measures, such as the Autism Spectrum Ques-
tionnaire (AQ [7]). A comprehensive neuropsychological
battery was administered. Mr. B.’s score on the Wechsler
Adult Intelligence Scale - 3rd edition (WAIS - III) indi-
cated that he has an average IQ (FSIQ = 92), with higher
verbal abilities than visuo-perceptive skills, and a signifi-
cantly slow processing speed, probably due to dyspraxia
and attentional difficulties. In memory tasks, Mr. B. is able
to encode and retrieve symbolic verbal information, such
as information about his restricted interests (e.g., newspa-
pers, history textbooks), but encoding and retrieval of
other types of verbal information are difficult. With most
of the visual episodic memory tasks, his results were
below average, especially with those that relied more on
attentional resources. His social cognition and empathy
skills as a whole are impaired. Furthermore, Mr. B.’s
neuropsychological profile is characterized by difficulties
with set-shifting and cognitive flexibility (in the Trail
Making Test, Hayling test, Six Elements Test, and with
verbal fluency tasks), weak central coherence—as observed
in his copy of the Rey-Osterrieth Complex Figure as well
as his highly developed memory for historical and cultural
facts (e.g., “Information” subtest of the WAIS-III)—and
social cognition impairments. His neuropsychological
profile is consistent with both the clinical picture already
described (behavioral and social rigidity, restricted inter-
ests, and impairments of mental attribution) and the major
neuropsychological theories applicable to ASDs.
Mr. B.’s treatment for his mood disorder in 2009 was
2 g valproic acid per day and 200 mg lamotrigine. To
avoid delirium tremens, his alcohol withdrawal was
managed with 30 mg diazepam per day. He received
900 mg acamprosate three times per day to prevent an
alcohol relapse but was unable to stop smoking. After a
three-month stay in hospital, he returned home and
continued his outpatient psychiatric and social care in
our department. Nevertheless, he was regularly hospital-
ized for alcohol intoxication combined with behavioral
disorders and depression. We increased the daily dosage
of valproic acid to 2.5 g and lamotrigine to 400 mg, and
in 2012 his mood disorder treatment was changed to 2 g
valproic acid and 200 mg quetiapine per day.
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The patient’s alcohol dependency was first treated
unsuccessfully with 50 mg per day naltrexone for more
than 3 months. We then switched to baclofen, which
was titrated over a 5- week period up to 170 mg per day.
However, he was unable to refrain for even 2 h from
buying a bottle of beer when he left the hospital. After
the HFA diagnosis, his follow-up care was re-organized
and adjusted to suit his clinical and cognitive function-
ing. Currently, his inpatient stays are programmed in
advance, last 3 days, and occur once a month. He has
psychiatric and psychological outpatient appointments
once and twice a week, respectively. They are scheduled
on the same days every week to encourage attendance
and to limit the anxiety associated with a change in rou-
tine. In addition to these environmental modifications,
his psychological follow-up was designed according to a
cognitive remediation and CBT-inspired framework, the
aims being to improve his cognitive flexibility and
problem-solving abilities, by means of behavioral exer-
cises involving role-playing and goal management train-
ing [8], as well as his social cognition abilities. Emotional
awareness and social role-playing were included at later
stages of his treatment. Mr. B. is now able to identify
and express some of his emotions. Appointments always
follow the same pattern, namely, identification of his emo-
tional state, followed by a review of his past and future
goals for the day, and discussion of a topical political issue.
After a year of twice-weekly treatment, Mr. B.’s social be-
havior is more reciprocal and flexible. His independent
functioning has also improved. He honors his appoint-
ments and tends to his apartment; nurses are able to
provide home care; and his alcohol consumption is limited
to 3 cans of beer per day.
Mr. T., a 55 year-old divorced man, was sent to us for
treatment for his addictions in 2011. After consulting
many psychiatrists and neurologists over the past few
decades, he had recently been diagnosed with Asperger
Syndrome by a specialized clinic. With respect to his
psychiatric history, he was hospitalized in 1973 for an-
orexia, and he had suffered from recurrent depressive
episodes that started in 2002 and were treated, to no
avail, with (successively) sertraline (200 mg per day for
3 months), fluoxetine (40 mg per day for 6 months) and
venlafaxine (250 mg per day for 1.5 months). At the end
of 2002, a neurologist treated him with 50 mg methyl-
phenidate per day for suspected ADHD, a diagnosis re-
lated to difficulties with working memory and attentional
tasks identified in a neuropsychological assessment. The
diagnosis was confirmed by a psychiatrist and the treat-
ment was continued. As the patient was afraid of becom-
ing dependent on his treatment and highly anxious after
taking it, he decided to take 20 mg only when he had to
give a lesson. However, his anxiety was so great that he
decided to give up treatment.
His brother has been diagnosed with an ASD. With
respect to Mr. T’s autobiographical history, he presented
difficulties with social skills and had no friends. He felt
different from others, and his interests were restricted to
languages, including German, Modern Greek, and French.
After attending a private primary school, he obtained a
master’s degree.
Mr. T. was addicted to strong black tea. He reported
drinking 10 cups of tea every morning to improve his
concentration and attentional abilities. A few hours after
drinking this large quantity of tea, he felt anxious and
complained of diarrhea, tremors, and epigastric pain.
This anxiety lasted all day. Social contact with Mr. T.
was difficult, although he was very talkative. His interac-
tions were one-sided. It required a lot of effort on his
part to understand other people’s behavior, and he
avoided eye contact. He found some sensory information
such as certain smells, like perfume, and noises made by
high heels, very distressing. Most of the time, because of
these sensory abnormalities, his social difficulties, and
the anxiety associated with change, he felt irritable,
anxious, and impulsive. With impairments in empathy
and social cognition, dysfunction in attention, working
memory, and executive abilities, and a detailed, rather
than global, information processing style (i.e., weak cen-
tral coherence), his neuropsychological profile was con-
sistent with his clinical picture and the HFA diagnosis.
In the evenings, he was so overwhelmed by his work
responsibilities that he drank two bottles of wine before
going to sleep. Because alcohol impaired his cognitive
and emotion-regulation abilities, Mr. T. found himself
trapped in a vicious cycle of dependency on psychosti-
mulants and alcohol. His high tea consumption helped
him to improve his attentional and organizational abil-
ities, but in the evening, his high level of excitation and
anxiety delayed sleep onset, and Mr. T. found relief in
drinking two bottles of wine each night. There was no
day of abstinence, and because he found it impossible to
give up strong tea and alcohol, he became dependent on
them (Alcohol Use Disorders Identification Test = 24).
We persuaded Mr. T. to start by reducing his alcohol
consumption. During the withdrawal phase, 20 mg di-
azepam was prescribed per day, mostly in the evening,
together with 900 mg acamprosate 3 times per day. The
dose of diazepam was rapidly lowered, but the patient
still experienced anxiety in the evening and relapsed.
Given that he refused to try an alternative pharmacological
treatment, his psychiatric medical care was discontinued,
and he started CBT and remediation cognitive therapy, ac-
cording to the principles described in the case of Mr. B.
However, unlike Mr. B., before beginning CBT and execu-
tive function remediation sessions, Mr. T. had 12 sessions
to try to improve his working memory by means of exer-
cises of increasing difficulty [9]. Furthermore, the aim of
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Mr. T.’s CBT and executive function remediation was to
improve his organizational and initiation skills, which
seemed to be a contributing factor to maintaining his high
levels of anxiety and some of his addictive behavior. The
patient reported some alleviation of executive and working
memory difficulties after therapy, but long-term feedback
is not available, because Mr. T. is no longer one of our
patients.
Discussion
Our report describes the cases of two adults with HFA
who were diagnosed late and who consumed high quan-
tities of alcohol and psychostimulants. A first analysis of
these descriptions could lead one to suppose that their
SUD was explained by their psychiatric co-morbidities,
namely depressive and anxiety disorders, which are often
associated with addictive behaviors [10, 11]. Indeed, Mr.
B had a mood disorder during the period of treatment.
Concerning Mr. T, past depressive episodes were re-
ported but this was no longer the case at the time of our
assessments. Furthermore, both patients reported that
their anxiety was associated with their behavioral and
social rigidity. Given the strong link between anxiety and
social rigidity, it is difficult to distinguish which of them
is particularly involved in alcohol use in this population.
As Matthew Tinsley reports in his book, social skill im-
pairments associated with autism could contribute to al-
cohol dependency in patients with psychiatric disorders
[4]. Godfrey et al. [12] showed that a belief that alcohol
may be able to enhance social skills and reduce anxiety
predicts the amount that alcohol-dependent individuals
consume. In our study, Mr. B. and Mr. T. reported that
they drank to reduce their anxiety associated with
unexpected events, sensory abnormalities, and social
events, and to improve their social skills. With regard to
schizophrenia, an FMRI study showed that patients who
suffered from co-morbid SUD (alcohol or cannabis) had
increased activation in the right superior parietal cortex
and left medial prefrontal cortex, both regions involved in
social cognition, and scored higher on a self-report scale
for subjective emotional experience than did non-abusing
patients [13]. These results suggest that socio-emotional
processing may be less impaired in dual-diagnosis (schizo-
phrenia and SUD) patients. In addition, Mr. B. and Mr. T.
presented with attentional and executive dysfunction and
attempted to improve their performance with psychosti-
mulants such as nicotine, caffeine, and tea. Kumar et al.
[14] suggest that cognitive and behavioral impairments in
patients with autism could be treated with psycho-
stimulants such as methylphenidate or nicotinic agonistic
agents. In fact, both our patients took psychostimulants to
improve their neurocognitive abilities, and in both cases,
their clinical picture was masked by their SUD, which
resulted in a delayed diagnosis of their developmental
illness. Acknowledging the clinical and neurocognitive
particularities of autism spectrum disorders, which
seemed particularly relevant in both our patients for
understanding the SUD, gave rise to psychotherapeutic
changes that enabled them to improve their overall
functioning.
Conclusion
Teaching addictologists and psychiatrists how better to
diagnose adult patients with autism could be useful from
two perspectives. First, it could allow for the identifica-
tion and better treatment of SUD in autism, the preva-
lence of which may be underestimated. Second, it could
also permit the identification of specific autism-related
mechanisms, such as cognitive inflexibility and change-
related anxiety, which may be a vulnerability trait for
developing substance-use disorders. Unless such mecha-
nisms are addressed, it is unlikely these patients will be
encouraged to change their SUD.
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